evolocumab - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
REPATHA evolocumab (rch) 420 mg/3.5 mL injection solution automated mini-doser AMD AUST R: 348651Active ingredients:
evolocumab
Dosage form:
Injection, solution
Sponsor:
Amgen Australia Pty Ltd
Phone:
1800 803 638
|
Deletion from market:
30 Jun 2024
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Manufacturing
Management action:
This product will be replaced by an alternative presentation - REPATHA evolocumab (rch) 140 mg/mL injection solution syringe within a pen injector ARTG 231152
|